2024-11-01 05:40:04
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab as Second-Line Therapy for Squamous Non-Small Cell Lung Cancer
Corporate/ 2023-07-23
Innovent Announces NMPA Acceptance of a ...

SAN FRANCISCO and SUZHOU,China,Jan. 12,2021-- Innovent Biologics,Inc. ("Innovent",HKEX: 01801),a world-class biopharmaceutical com...

Techorizon announces the launch of the latest version of THeCRF 4.0
Health/ 2023-07-22
Techorizon announces the launch of the l...

VERONA,Italy,Jan. 12,2021-- Techorizon,a worldwide provider of technology solutions for the Life Sciences industry founded in 2009,announced...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release